Leveraging Vaccines to Reduce Antibiotic Use and Prevent Antimicrobial Resistance: A World Health Organization Action Framework.

Autor: Vekemans J; Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), Geneva, Switzerland., Hasso-Agopsowicz M; Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), Geneva, Switzerland., Kang G; Division of Gastrointestinal Sciences, Christian Medical College, Vellore TN, India., Hausdorff WP; PATH, Washington, District of Columbia, USA Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium., Fiore A; Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Tayler E; Antimicrobial Resistance Division, World Health Organization (WHO), Geneva, Switzerland., Klemm EJ; Wellcome Trust, Bloomsbury, London, United Kingdom., Laxminarayan R; Center for Disease Dynamics, Economics & Policy, Washington District of Columbia, USA., Srikantiah P; Bill and Melinda Gates Foundation, Seattle, Washington, USA., Friede M; Immunization, Vaccines and Biologicals (IVB), World Health Organization (WHO), Geneva, Switzerland., Lipsitch M; Harvard T. H. Chang School of Public Medicine, Boston, Massachusetts, USA.
Jazyk: angličtina
Zdroj: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2021 Aug 16; Vol. 73 (4), pp. e1011-e1017.
DOI: 10.1093/cid/ciab062
Databáze: MEDLINE